Braveheart Bio, Inc. (BRVE)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $18.60
- As of
Kresmion compiles this page from BRVE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Braveheart Bio, Inc. (BRVE): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-06.
See the full BRVE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BRVE on one page. Preview it with sample data, then open it live with a free account.
Preview the BRVE dossierActive events for BRVE
- mediumEarnings below estimates
Q2-2026: Missed consensus by 157.1%, EPS $-2.51 vs $4.3996 estimate
FREE, NO ACCOUNT
Every event on BRVE, as it fires
New filings, 13F moves and cross asset events on BRVE land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, BRVE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on BRVE
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BRVE on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BRVE in the last 180 days.
Upstream: SEC EDGAR filings for BRVE
Kresmion, "Braveheart Bio, Inc. (BRVE) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/BRVE. Upstream data: SEC EDGAR filings for BRVE.
Link to this data (HTML):
<a href="https://kresmion.com/research/BRVE">Braveheart Bio, Inc. (BRVE) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BRVE on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BRVE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.